CN111031813A - 用于预防和治疗心血管器官病症的组合物 - Google Patents

用于预防和治疗心血管器官病症的组合物 Download PDF

Info

Publication number
CN111031813A
CN111031813A CN201880045110.6A CN201880045110A CN111031813A CN 111031813 A CN111031813 A CN 111031813A CN 201880045110 A CN201880045110 A CN 201880045110A CN 111031813 A CN111031813 A CN 111031813A
Authority
CN
China
Prior art keywords
composition
iron
lecithin
salt
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880045110.6A
Other languages
English (en)
Chinese (zh)
Inventor
A·拉考尔特
G·塔伦蒂诺
E·布里利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Falmantra
Original Assignee
Falmantra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Falmantra filed Critical Falmantra
Publication of CN111031813A publication Critical patent/CN111031813A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/714—Vitamin K
    • A23V2250/7144—Vitamin K2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201880045110.6A 2017-07-26 2018-07-26 用于预防和治疗心血管器官病症的组合物 Pending CN111031813A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085412A IT201700085412A1 (it) 2017-07-26 2017-07-26 Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT102017000085412 2017-07-26
PCT/IB2018/055586 WO2019021232A1 (en) 2017-07-26 2018-07-26 Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus

Publications (1)

Publication Number Publication Date
CN111031813A true CN111031813A (zh) 2020-04-17

Family

ID=60451085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880045110.6A Pending CN111031813A (zh) 2017-07-26 2018-07-26 用于预防和治疗心血管器官病症的组合物

Country Status (19)

Country Link
US (1) US20200206157A1 (enExample)
EP (1) EP3657963A1 (enExample)
JP (2) JP2020528888A (enExample)
KR (1) KR20200032691A (enExample)
CN (1) CN111031813A (enExample)
BR (1) BR112020000902B1 (enExample)
CA (1) CA3070659A1 (enExample)
CL (1) CL2020000170A1 (enExample)
CO (1) CO2020000526A2 (enExample)
EA (1) EA202090069A1 (enExample)
IL (1) IL272138B2 (enExample)
IT (1) IT201700085412A1 (enExample)
JO (1) JOP20200012A1 (enExample)
MA (1) MA49794A (enExample)
MX (1) MX2020000806A (enExample)
PE (1) PE20200794A1 (enExample)
PH (1) PH12020550031A1 (enExample)
WO (1) WO2019021232A1 (enExample)
ZA (1) ZA202000461B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
CA3102977A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating tissue calcification
EP3801478A4 (en) 2018-06-08 2022-02-23 Epizon Pharma, Inc. METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF CALCIPHYLAXIA
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
CN114748486A (zh) * 2022-03-25 2022-07-15 南京盛德生物科技研究院有限公司 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用
CA3254376A1 (en) 2022-05-31 2023-12-07 Region Syddanmark Vitamin K2 intended for use in the treatment of coronary artery calcification

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08253415A (ja) * 1994-04-28 1996-10-01 Eisai Co Ltd 抗動脈硬化治療剤
US6039978A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Dietary food enhancement agent
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US20050261257A1 (en) * 2002-08-30 2005-11-24 Vitak Bv Compositions for treating or preventing cardiovascular disease
US20070148258A1 (en) * 2003-10-28 2007-06-28 O'neill W C Dialysates and methods and systems related thereto
US20070148259A1 (en) * 2005-12-23 2007-06-28 Ajay Gupta Parenteral nutrition composition containing iron
US20090186939A1 (en) * 2006-01-30 2009-07-23 Keith Chan Method of Treating Chronic Kidney Disease
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
US20110294665A1 (en) * 2008-12-25 2011-12-01 I.B.E. Co., Ltd. Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
US20150250885A1 (en) * 2012-07-31 2015-09-10 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions
US20160310445A1 (en) * 2013-12-20 2016-10-27 Vitak Bv Prevention and counteraction of diet-induced thrombosis risk

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281888A1 (en) * 2004-06-16 2005-12-22 Chandra Ranjit K Nutritional supplement for infants
WO2006055526A2 (en) * 2004-11-16 2006-05-26 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US20180199610A1 (en) * 2015-02-20 2018-07-19 Vitak B.V. Vitamin k and capillary function
US11344575B2 (en) * 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08253415A (ja) * 1994-04-28 1996-10-01 Eisai Co Ltd 抗動脈硬化治療剤
US6039978A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Dietary food enhancement agent
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US20050261257A1 (en) * 2002-08-30 2005-11-24 Vitak Bv Compositions for treating or preventing cardiovascular disease
US20070148258A1 (en) * 2003-10-28 2007-06-28 O'neill W C Dialysates and methods and systems related thereto
US20070148259A1 (en) * 2005-12-23 2007-06-28 Ajay Gupta Parenteral nutrition composition containing iron
US20090186939A1 (en) * 2006-01-30 2009-07-23 Keith Chan Method of Treating Chronic Kidney Disease
US20100021573A1 (en) * 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
US20110294665A1 (en) * 2008-12-25 2011-12-01 I.B.E. Co., Ltd. Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
WO2012161572A1 (en) * 2011-05-20 2012-11-29 Friesland Brands B.V. Composition comprising vitamin k2
US20150250885A1 (en) * 2012-07-31 2015-09-10 Alesco S.R.L. Solid composition comprising iron for use in iron deficient conditions
US20160310445A1 (en) * 2013-12-20 2016-10-27 Vitak Bv Prevention and counteraction of diet-induced thrombosis risk

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ELLEN NEVEN ET AL: ""Iron and vascular calcification. Is there a link?"" *

Also Published As

Publication number Publication date
JOP20200012A1 (ar) 2020-01-26
US20200206157A1 (en) 2020-07-02
IT201700085412A1 (it) 2019-01-26
BR112020000902A2 (pt) 2020-07-21
CL2020000170A1 (es) 2020-10-30
WO2019021232A1 (en) 2019-01-31
JP2023090869A (ja) 2023-06-29
ZA202000461B (en) 2021-03-31
IL272138B1 (en) 2023-05-01
BR112020000902B1 (pt) 2024-03-12
CO2020000526A2 (es) 2020-02-18
JP2020528888A (ja) 2020-10-01
IL272138B2 (en) 2023-09-01
IL272138A (en) 2020-03-31
EP3657963A1 (en) 2020-06-03
PE20200794A1 (es) 2020-08-10
CA3070659A1 (en) 2019-01-31
EA202090069A1 (ru) 2020-04-10
MX2020000806A (es) 2020-08-17
PH12020550031A1 (en) 2021-02-08
KR20200032691A (ko) 2020-03-26
MA49794A (fr) 2020-06-03

Similar Documents

Publication Publication Date Title
CN111031813A (zh) 用于预防和治疗心血管器官病症的组合物
Kapoor et al. Coenzyme Q10-a novel molecule
JP4205943B2 (ja) 天然および合成ｈｃａのバイオアベイラブルな組成物
Fuster et al. Plant phosphates, phytate and pathological calcifications in chronic kidney disease
RS58102B1 (sr) Lečenje hematoloških maligniteta sa anti-cxcr4 antitelom
CN104602674A (zh) 用于缺铁病况的含铁固体组合物
DE60317639T3 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
US20070009590A1 (en) Physiologically active composition based on phosphatidylserine
CZ301495B6 (cs) Fosfolipidové komplexy
JP2001506277A (ja) マグネシウム吸収を高め、アテローム性動脈硬化症を防ぐ方法
WO2022190072A1 (en) Iron(iii) formulations for the treatment of gastrointestinal inflammation
KR20220122654A (ko) 미네랄 및/또는 비타민 및 폴리사카라이드를 포함하는 제제, 그 조성물, 및 미네랄 및/또는 비타민 보충에서 그 용도
HK40018499A (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
WO2019239372A1 (en) Composition comprising sucrosomial minerals containing mineral salts for use in conditions of deficiency of such minerals
HU227182B1 (en) Lecitin-ascorbic acid combination
EA046793B1 (ru) Применение композиции (варианты) для профилактического или терапевтического лечения кальцификации сосудов
US20250275982A1 (en) Solid form formulation comprising chromium or copper or a vitamin, compositions and uses thereof
JP2005522485A (ja) 石灰化された動脈プラークの蓄積および細胞の機能不全を軽減し、イオンカルシウムの釣合いをとるための方法
WO2021125342A1 (ja) 肥満抑制用組成物
WO2012119049A2 (en) Nutritional compositions comprising prune extract and bioavailable curcumin
EP4401578A1 (en) Chondroprotective nutraceutical composition and method of using same
IL322591A (en) New oral compositions of iron and acacia resin, a process for their preparation and their use in situations of iron deficiency
HK40019663A (en) Solid composition comprising iron for use in iron deficient conditions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40018499

Country of ref document: HK

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200417